Gaudium IVF & Women Health Fair Value
Gaudium IVF & Women Health (GAUDIUMIVF) average fair value is ₹21.34 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹124.39 (-82.84%), fair value range ₹2.96–₹38.95. See GAUDIUMIVF price to book ratio to compare market price against book value per share.
Fair Value Analysis Export
GAUDIUMIVF Fair Value vs Current Price — Valuation Summary
GAUDIUMIVF average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit GAUDIUMIVF share price screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
GAUDIUMIVF Fair Value Analysis — Data Sources & Coverage
Gaudium IVF & Women Health financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine GAUDIUMIVF earnings for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
GAUDIUMIVF vs Healthcare Sector Peers — P/E, P/B & Market Cap
Gaudium IVF & Women Health P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Auro Laboratories | AUROLAB | 91.49 | 3.91 | ₹165 |
| Sun Pharmaceutical | SUNPHARMA | 41.43 | 5.83 | ₹442,581 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.